You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 2, February 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  LETTERS TO THE EDITOR
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ampicillin-Resistant Listeria monocytogenes Meningitis

S. S. Pollock, MD, MRCP; T. M. Pollock, FFCM, FRCP; M. J. G. Harrison, DM, FRCP
Manchester Royal Infirmary Oxford Road Manchester M13 9WL, England

Arch Neurol. 1986;43(2):106.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We read with interest the report by Rapp et al1 of the occurrence of ampicillin-resistant Listeria monocytogenes meningitis in a previously healthy 14-year-old athlete. We have recently reviewed 54 cases of proven juvenile and adult listerial infection of the central nervous system (CNS) reported to the Public Health Laboratory Service in England and Wales between 1975 and 1980.2 Of the ten patients who received ampicillin as the initial sole antibiotic, resistance to the drug was noted in two instances, but recovery followed a change to chloramphenicol. However, the latter drug, which was used as the initial therapy in five cases, also had to be changed in two instances because of resistance. Moreover, one patient, a woman aged 63 years with diabetes and pemphigus for which she was receiving gold sodium thiomalate, cosyntropin, and azathioprine, developed a fatal agranulocytosis. It has been reported3 that the . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.